We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
2022-01-04
US approval of Pfizer's anti-Covid pill and studies indicating Omicron infections were less likely to result in hospitalisation have cheered markets.
2022-01-03
